Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$361M |
| 2 |
CVS Health
CVS
|
+$180M |
| 3 |
Cigna
CI
|
+$158M |
| 4 |
Microsoft
MSFT
|
+$102M |
| 5 |
Amazon
AMZN
|
+$90M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$301M |
| 2 |
AET
Aetna Inc
AET
|
+$270M |
| 3 |
PX
Praxair Inc
PX
|
+$184M |
| 4 |
ANDV
Andeavor
ANDV
|
+$97.3M |
| 5 |
COL
Rockwell Collins
COL
|
+$89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.86% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 10.39% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Pacific Biosciences
PACB
$435M
| $5.57M | ﹤0.01% |
752,343
+78,493
| +12% | +$497K |
|
1852
Brown-Forman Class A
BF.A
$13.4B
| $5.55M | ﹤0.01% |
117,126
+7,320
| +7% | +$349K |
|
|
HSII
1853
DELISTED
Heidrick & Struggles
HSII
| $5.54M | ﹤0.01% |
177,676
+4,589
| +3% | +$150K |
|
|
INOV
1854
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $5.54M | ﹤0.01% |
390,291
+2,053
| +0.5% | +$23.4K |
|
1855
M/I Homes
MHO
$3.74B
| $5.53M | ﹤0.01% |
263,077
+5,538
| +2% | +$128K |
|
|
DENN
1856
DELISTED
Denny's
DENN
| $5.52M | ﹤0.01% |
340,532
-8,366
| -2% | -$132K |
|
1857
Editas Medicine
EDIT
$396M
| $5.52M | ﹤0.01% |
242,630
-226
| -0.1% | -$6.15K |
|
1858
Heritage Financial
HFWA
$1.22B
| $5.51M | ﹤0.01% |
185,420
-1,071
| -0.6% | -$35K |
|
|
CHS
1859
DELISTED
Chicos FAS, Inc.
CHS
| $5.51M | ﹤0.01% |
979,728
-5,174
| -0.5% | -$36K |
|
1860
SK Telecom
SKM
$12.1B
| $5.5M | ﹤0.01% |
124,641
-8,323
| -6% | -$370K |
|
1861
Tompkins Financial
TMP
$1.43B
| $5.5M | ﹤0.01% |
73,363
-292
| -0.4% | -$22.4K |
|
1862
Insmed
INSM
$21.4B
| $5.5M | ﹤0.01% |
419,333
+1,594
| +0.4% | +$25.4K |
|
1863
Lakeland Financial Corp
LKFN
$1.56B
| $5.5M | ﹤0.01% |
136,899
-1,570
| -1% | -$68.3K |
|
|
ITG
1864
DELISTED
Investment Technology Group Inc
ITG
| $5.48M | ﹤0.01% |
181,255
+953
| +0.5% | +$27.3K |
|
|
ALX
1865
Alexander's
ALX
$1.3B
| $5.48M | ﹤0.01% |
17,971
-176
| -1% | -$56.1K |
|
|
ESIO
1866
DELISTED
Electro Scientific Industries
ESIO
| $5.47M | ﹤0.01% |
182,663
-54,860
| -23% | -$1.36M |
|
|
CSII
1867
DELISTED
Cardiovascular Systems, Inc.
CSII
| $5.45M | ﹤0.01% |
191,269
+9,215
| +5% | +$293K |
|
|
MNTA
1868
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $5.44M | ﹤0.01% |
492,950
+62,599
| +15% | +$871K |
|
1869
Artivion
AORT
$1.3B
| $5.43M | ﹤0.01% |
191,425
-515
| -0.3% | -$15.5K |
|
1870
ANI Pharmaceuticals
ANIP
$1.8B
| $5.42M | ﹤0.01% |
120,398
+14,593
| +14% | +$765K |
|
1871
Seaboard Corp
SEB
$4.23B
| $5.42M | ﹤0.01% |
1,532
-3
| -0.2% | -$11.1K |
|
|
EBIX
1872
DELISTED
Ebix Inc
EBIX
| $5.41M | ﹤0.01% |
127,173
-334
| -0.3% | -$17.8K |
|
|
PRFT
1873
DELISTED
Perficient Inc
PRFT
| $5.38M | ﹤0.01% |
241,752
+11,595
| +5% | +$285K |
|
|
HIBB
1874
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $5.38M | ﹤0.01% |
375,842
-337
| -0.1% | -$5.73K |
|
|
GTY
1875
Getty Realty Corp
GTY
$2.11B
| $5.36M | ﹤0.01% |
182,072
+870
| +0.5% | +$25.1K |
|
Similar funds
Charles Schwab's Q4 2018 Portfolio in Review
As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
- Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
- Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
- Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
- Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
- Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
- Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.
Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.